Literature DB >> 17237383

Mitogenic CD28 signals require the exchange factor Vav1 to enhance TCR signaling at the SLP-76-Vav-Itk signalosome.

Kevin M Dennehy1, Fernando Elias, Shin-Young Na, Klaus-Dieter Fischer, Thomas Hünig, Fred Lühder.   

Abstract

Almost all physiological T cell responses require costimulation-engagement of the clonotypic TCR with MHC/Ag and CD28 by its ligands CD80/86. Whether CD28 provides signals that are qualitatively unique or quantitatively amplify TCR signaling is poorly understood. In this study, we use superagonistic CD28 Abs, which induce T cell proliferation without TCR coligation, to determine how CD28 contributes to mitogenic responses. We show that mitogenic CD28 signals require but do not activate the proximal TCR components TCRzeta and Zap-70 kinase. In cell lines lacking proximal TCR signaling, an early defect in the CD28 pathway is in phosphorylation of the adaptor molecule SLP-76, which we show is essential for recruitment of the exchange factor Vav leading to Ca(2+) flux and IL-2 production. Point mutations in CD28 that result in diminished Vav phosphorylation also result in defective Ca(2+) flux, IL-2 production, and Tec-kinase phosphorylation. Using Vav1-deficient mice, we further demonstrate the importance of Vav1 for efficient proliferation, IL-2 production, and Ca(2+) flux. Our results indicate that CD28 signals feed into the TCR signaling pathway at the level of the SLP-76 signalosome.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17237383     DOI: 10.4049/jimmunol.178.3.1363

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

1.  The storm has cleared: lessons from the CD28 superagonist TGN1412 trial.

Authors:  Thomas Hünig
Journal:  Nat Rev Immunol       Date:  2012-04-10       Impact factor: 53.106

2.  A CD28 superagonistic antibody elicits 2 functionally distinct waves of T cell activation in rats.

Authors:  Nora Müller; Jens van den Brandt; Francesca Odoardi; Denise Tischner; Judith Herath; Alexander Flügel; Holger M Reichardt
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

3.  Recruitment of the cytoplasmic adaptor Grb2 to surface IgG and IgE provides antigen receptor-intrinsic costimulation to class-switched B cells.

Authors:  Niklas Engels; Lars Morten König; Christina Heemann; Johannes Lutz; Takeshi Tsubata; Sebastian Griep; Verena Schrader; Jürgen Wienands
Journal:  Nat Immunol       Date:  2009-08-09       Impact factor: 25.606

4.  Selective expansion of memory CD4(+) T cells by mitogenic human CD28 generates inflammatory cytokines and regulatory T cells.

Authors:  Manisha Singh; Sreemanti Basu; Christina Camell; Jacob Couturier; Rodolfo J Nudelman; Miguel A Medina; John R Rodgers; Dorothy E Lewis
Journal:  Eur J Immunol       Date:  2008-06       Impact factor: 5.532

5.  Replacing CAR-T cell resistance with persistence by changing a single residue.

Authors:  Emily M Hsieh; Lauren D Scherer; Rayne H Rouce
Journal:  J Clin Invest       Date:  2020-06-01       Impact factor: 14.808

6.  Genome-wide CRISPR Screens in Primary Human T Cells Reveal Key Regulators of Immune Function.

Authors:  Eric Shifrut; Julia Carnevale; Victoria Tobin; Theodore L Roth; Jonathan M Woo; Christina T Bui; P Jonathan Li; Morgan E Diolaiti; Alan Ashworth; Alexander Marson
Journal:  Cell       Date:  2018-11-15       Impact factor: 41.582

7.  Single residue in CD28-costimulated CAR-T cells limits long-term persistence and antitumor durability.

Authors:  Sonia Guedan; Aviv Madar; Victoria Casado-Medrano; Carolyn Shaw; Anna Wing; Fang Liu; Regina M Young; Carl H June; Avery D Posey
Journal:  J Clin Invest       Date:  2020-06-01       Impact factor: 14.808

8.  A novel form of 4-1BBL has better immunomodulatory activity than an agonistic anti-4-1BB Ab without Ab-associated severe toxicity.

Authors:  Rich-Henry Schabowsky; Kutlu G Elpek; Shravan Madireddi; Rajesh K Sharma; Esma S Yolcu; Laura Bandura-Morgan; Robert Miller; Kathryn J MacLeod; Robert S Mittler; Haval Shirwan
Journal:  Vaccine       Date:  2009-10-29       Impact factor: 3.641

9.  Stimulatory and suppressive signal transduction regulates vasoactive intestinal peptide receptor-1 (VPAC-1) in primary mouse CD4 T cells.

Authors:  Emilie E Vomhof-DeKrey; Glenn Paul Dorsam
Journal:  Brain Behav Immun       Date:  2008-06-13       Impact factor: 7.217

10.  IL-2 regulates expression of C-MAF in human CD4 T cells.

Authors:  Aradhana Rani; Behdad Afzali; Audrey Kelly; Lemlem Tewolde-Berhan; Mark Hackett; Aditi S Kanhere; Isabela Pedroza-Pacheco; Holly Bowen; Stipo Jurcevic; Richard G Jenner; David J Cousins; Jack A Ragheb; Paul Lavender; Susan John
Journal:  J Immunol       Date:  2011-08-29       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.